In multiple sclerosis, the immune system mistakenly attacks and harms myelin, which is the “sheath” that protects axons (or the projection that links nerve cells to one another and lets them communicate). This can result in muscle weakness, fatigue, coordination problems, and chronic pain.
So far, no cure has been developed for multiple sclerosis (MS), and available treatments focus on managing the symptoms. Some suggest that specific dietary interventions could help with the management of MS, but as yet, there is insufficient research to lend full support to such claims.
Now, specialists from Washington University School of Medicine in St. Louis, MO, and the Jackson Laboratory for Genomic Medicine in Farmington, CT, are testing the effectiveness of one dietary approach in the management of this condition: intermittent fasting.
Excerpted from Medical News Today